CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Back to AGY.L

Dihydroartemisinin-piperaquine (DP)

Phase 3
Allergy Therapeutics plc (AGY.L)

Phase 3

Development Phase

1

Upcoming Catalysts

0

Historical Events

0

Regulatory Approvals

Upcoming Catalysts
What are catalysts?
Q2 '27
AGY.LPhase 3

Dihydroartemisinin-piperaquine (DP) Phase 3 Est. Readout

Dihydroartemisinin-piperaquine (DP)
Q2 2027~Q
CT.gov
00%
Competitive Landscape
Drug Information

Target Indication

Malaria

Clinical Trial

NCT04978272

Last updated: 9/3/2026

Patent & Exclusivity

No patent data available. Pre-approval drugs may not have Orange Book listings.

Drug Science
Mechanism of action & safety profile
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts

Weekly digest every Monday. Unsubscribe anytime.